{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:36:50Z","timestamp":1764002210397,"version":"3.41.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/rheumatology\/key197","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T11:07:56Z","timestamp":1529060876000},"page":"2101-2105","source":"Crossref","is-referenced-by-count":22,"title":["Certolizumab pegol in the treatment of Takayasu arteritis"],"prefix":"10.1093","volume":"57","author":[{"given":"Pavel I","family":"Novikov","sequence":"first","affiliation":[{"name":"Tareev Clinic of Internal Diseases, Sechenov First State Moscow Medical University, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya O","family":"Smitienko","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Medical Center K+31, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V","family":"Sokolova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Alibaz-Oner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Kaymaz-Tahra","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey V","family":"Moiseev","sequence":"additional","affiliation":[{"name":"Tareev Clinic of Internal Diseases, Sechenov First State Moscow Medical University, Moscow, Russia"},{"name":"Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"key\n\t\t\t\t2018112705031742300_key197-B1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B4","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.114.014321","article-title":"Efficacy of biological-targeted treatments in takayasu arteritis: multicenter, retrospective study of 49 patients","volume":"132","author":"Mekinian","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ker380","article-title":"Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study","volume":"51","author":"Mekinian","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.semarthrit.2016.07.012","article-title":"Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature","volume":"46","author":"Batu","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/rheumatology\/kei266","article-title":"Serum cytokine profiles and their correlations with disease activity in Takayasu\u2019s arteritis","volume":"45","author":"Park","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B8","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B9","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0016-5085(10)63101-0","article-title":"W1208 No significant transfer of certolizumab pegol compared with IgG in the perfused human placenta in vitro","volume":"138","author":"Porter","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B11","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-eular.1640","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","author":"Mariette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B12","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0167-5273(96)88783-3","article-title":"Diagnostic criteria for Takayasu arteritis","volume":"54 Suppl","author":"Sharma","year":"1996","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2014.01.012","article-title":"Diagnostic and classification criteria of Takayasu arteritis","volume":"48\u201349","author":"De Souza","year":"2014","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.injr.2015.08.006","article-title":"Assessment of disease activity in Takayasu\u2019s arteritis","volume":"10","author":"Misra","year":"2015","journal-title":"Indian J Rheumatol"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/acr.21636","article-title":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup","volume":"64","author":"Schmidt","year":"2012","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2011.11.025","article-title":"Anti TNF-\u03b1 in refractory Takayasu\u2019s arteritis: cases series and review of the literature","volume":"11","author":"Comarmond","year":"2012","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B17","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10067-013-2380-6","article-title":"Tumor necrosis factor alpha inhibitors in patients with Takayasu\u2019s arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature","volume":"32","author":"Novikov","year":"2013","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/rheumatology\/kev366","article-title":"Outcome assessment in Takayasu arteritis","volume":"55","author":"Nakagomi","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jim.2009.06.009","article-title":"Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis","volume":"348","author":"Palframan","year":"2009","journal-title":"J Immunol Methods"},{"key":"key\n\t\t\t\t2018112705031742300_key197-B22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3858\/emm.2011.43.10.063","article-title":"One target, different effects: a comparison of distinct therapeutic antibodies against the same targets","volume":"43","author":"Shim","year":"2011","journal-title":"Exp Mol Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/57\/12\/2101\/26769372\/key197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:21:40Z","timestamp":1751689300000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/57\/12\/2101\/5053239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,7,12]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key197","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,7,12]]}}}